Abstract
Oncolytic alphavirus M1 has been shown to selectively target and kill cancer cells, but cytopathic morphologies induced by M1 virus and the life cycle of the M1 strain in cancer cells remain unclear. Here, we study the key stages of M1 virus infection and replication in the M1 virus-sensitive HepG2 liver cancer cell line by transmission electron microscopy, specifically examining viral entry, assembly, maturation and release. We found that M1 virus induces vacuolization of cancer cells during infection and ultimately nuclear marginalization, a typical indicator of apoptosis. Specifically, our results suggest that the endoplasmic reticulum participates in the assembly of nucleocapsids. In the early and late stage of infection, three kinds of special cytopathic vacuoles are formed and appear to be involved in the replication, maturation and release of the virus. Taken together, our data displayed the process of M1 virus infection of tumor cells and provide the structural basis for the study of M1 virus-host interactions.
Similar content being viewed by others
Change history
15 July 2021
A Correction to this paper has been published: https://doi.org/10.1007/s12250-021-00429-0
References
Acheson NH, Tamm I (1967) Replication of Semliki Forest Virus: an electron microscopic study. Virol 32:128–143
Anwanwan D, Singh SK, Singh S, Saikam V, Singh R (2020) Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer 1873:188314
Cai J, Lin Y, Zhang H, Liang J, Tan Y, Cavenee WK, Yan G (2017) Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics. Proc Natl Acad Sci USA 114:6812–6817
Cossart P, Helenius A (2014) Endocytosis of Viruses and Bacteria. Cold Spring Harb Perspect Biol 6:a016972–a016972
DeTulleo L, Kirchhausen T (1998) The clathrin endocytic pathway in viral infection. EMBO J 17:4585–4593
Eissa IR, Bustos-Villalobos I, Ichinose T, Matsumura S, Naoe Y, Miyajima N, Morimoto D, Mukoyama N, Zhiwen W, Tanaka M, Hasegawa H, Sumigama S, Aleksic B, Kodera Y, Kasuya H (2018) The current status and future prospects of oncolytic viruses in clinical trials against melanoma, glioma, pancreatic, and breast cancers. Cancers (Basel) 10:356
Forrester NL, Palacios G, Tesh RB, Savji N, Guzman H, Sherman M, Weaver SC, Lipkin WI (2012) Genome-scale phylogeny of the alphavirus genus suggests a marine origin. J Virol 86:2729–2738
Frolova EI, Gorchakov R, Pereboeva L, Atasheva S, Frolov I (2010) Functional sindbis virus replicative complexes are formed at the plasma membrane. J Virol 84:11679–11695
Grimley PM, Berezesky IK, Friedman RM (1968) Cytoplasmic structures associated with an arbovirus infection: loci of viral ribonucleic acid synthesis. J Virol 2:1326–1338
Hang Z, Wei Y, Zhao X (1996) Electron microscopic observation of hepato cellular carcinoma in 15 cases–an ultrastructural comparison with human embryonic liver. Hua Xi Yi Ke Da Xue Xue Bao 27:332–336 ((in Chinese))
Kääriäinen L, Keränen S, Lachmi B, Söderlund H, Tuomi K, Ulmanen I (1975) Replication of Semliki Forest Virus. Med Biol 53:342–351
Kallio K, Hellstrom K, Jokitalo E, Ahola T (2016) RNA replication and membrane modification require the same functions of alphavirus nonstructural proteins. J Virol 90:1687–1692
Kimanius D, Forsberg BO, Scheres SH, Lindahl E (2016) Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2. Elife 5:e18722
Lim EXY, Lee WS, Madzokere ET, Herrero LJ (2018) Mosquitoes as suitable vectors for alphaviruses. Virus 10:84
Lin Y, Zhang H, Liang J, Li K, Zhu W, Fu L, Wang F, Zheng X, Shi H, Wu S, Xiao X, Chen L, Tang L, Yan M, Yang X, Tan Y, Qiu P, Huang Y, Yin W, Su X, Hu H, Hu J, Yan G (2014) Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers. Proc Natl Acad Sci USA 111:E4504–E4512
Lundstrom K (2014) Alphavirus-based vaccines. Virus 6:2392–2415
Lundstrom K (2016) Alphavirus vectors as tools in neuroscience and gene therapy. Virus Res 216:16–25
Lundstrom K (2017) Oncolytic alphaviruses in cancer immunotherapy. Vaccin 5:9
Markoff L (2015) Chapter 153 - Alphaviruses. In: Bennett JE, Dolin R, Blaser ML (eds) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, 8th edn. Elsevier, Philadelphia, pp 1865-1874.e2
Marks M, Marks JL (2016) Viral arthritis. Clin Med 16:129–134
Mendes A, Kuhn RJ (2018) Alphavirus Nucleocapsid Packaging and Assembly. Virus 10:138
Pol J, Kroemer G, Galluzzi L (2016) First oncolytic virus approved for melanoma immunotherapy. Oncoimmunol 5:e1115641
Raja J, Ludwig JM, Gettinger SN, Schalper KA, Kim HS (2018) Oncolytic virus immunotherapy: future prospects for oncology. J Immunother Cancer 6:140
Ribas A, Dummer R, Puzanov I, VanderWalde A, Andtbacka RHI, Michielin O, Olszanski AJ, Malvehy J, Cebon J, Fernandez E, Kirkwood JM, Gajewski TF, Chen L, Gorski KS, Anderson AA, Diede SJ, Lassman ME, Gansert J, Hodi FS, Long GV (2017) Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy. Cell 170:1109-1119.e10
Soonsawad P, Xing L, Milla E, Espinoza JM, Kawano M, Marko M, Hsieh C, Furukawa H, Kawasaki M, Weerachatyanukul W, Srivastava R, Barnett SW, Srivastava IK, Cheng RH (2010) Structural evidence of glycoprotein assembly in cellular membrane compartments prior to alphavirus budding. J Virol 84:11145–11151
Spuul P, Balistreri G, Kääriäinen L, Ahola T (2010) Phosphatidylinositol 3-kinase-, actin-, and microtubule-dependent transport of Semliki Forest Virus replication complexes from the plasma membrane to modified lysosomes. J Virol 84:7543–7657
Strauss JH, Strauss EG, Kuhn RJ (1995) Budding of alphaviruses. Trends Microbiol 3:346–350
Tan Y, Lin Y, Li K, Xiao X, Liang J, Cai J, Guo L, Li C, Zhu W, Xing F, Mai J, Gu J, Tan X, Yin W, Lu B, Qiu P, Su X, Gao M, Hu J, He S, Lu L, Gong S, Yan G, Zhang H (2018) Selective antagonism of Bcl-xL potentiates M1 oncolysis by enhancing mitochondrial apoptosis. Hum Gene Ther 29:950–961
Tang G, Peng L, Baldwin PR, Mann DS, Jiang W, Rees I, Ludtke SJ (2007) EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol 157:38–46
Taylor A, Herrero LJ, Rudd PA, Mahalingam S (2015) Mouse models of alphavirus-induced inflammatory disease. J Gen Virol 96:221–238
Weaver SC, Paessler S (2009) Chapter 21-alphaviral encephalitides. In: Barrett ADT, Stanberry LR (eds) Vaccines for biodefense and emerging and neglected diseases. Academic Press, London, pp 339–359
Zhang H, Li K, Lin Y, Xing F, Xiao X, Cai J, Zhu W, Liang J, Tan Y, Fu L, Wang F, Yin W, Lu B, Qiu P, Su X, Gong S, Bai X, Hu J, Yan G (2017) Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma. Sci Transl Med 9:eaaam7996
Zhang H, Lin Y, Li K, Liang J, Xiao X, Cai J, Tan Y, Xing F, Mai J, Li Y, Chen W, Sheng L, Gu J, Zhu W, Yin W, Qiu P, Su X, Lu B, Tian X, Liu J, Lu W, Dou Y, Huang Y, Hu B, Kang Z, Gao G, Mao Z, Cheng SY, Lu L, Bai XT, Gong S, Yan G, Hu J (2016) Naturally existing oncolytic virus m1 is nonpathogenic for the nonhuman primates after multiple rounds of repeated intravenous injections. Hum Gene Ther 27:700–711
Zhang R, Hryc CF, Cong Y, Liu X, Jakana J, Gorchakov R, Baker ML, Weaver SC, Chiu W (2011) 4.4 Å cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus. EMBO J 30:3854–3863
Acknowledgements
This research was supported by the Science and Technology Program of Guangzhou (201707020003), the Pioneering Talents Project of Guangzhou Development Zone, Guangdong Province (CY2018-012), the Guangzhou People's Livelihood Science and Technology Tackling Key Project (201803010113), the Young Teacher Training Program of Sun Yat-sen University (20ykpy22), and the National Natural Science Foundation of China (No. 81802536).
Author information
Authors and Affiliations
Contributions
JD contributed to the experimental design and cellular experiments. JD and LN contributed to the EM observations, data analyses, manuscript writing and editing. XJ contributed to the 2D classification. JC, YL, JL, JH, GY and WZ contributed to the operations at the TEM facilities. YL and DC contributed to TEM sample preparation. CX, YL and CH contributed to the data analyses. JL and QZ contributed to the manuscript revisions. QZ contributed to the EM observations, data analyses, and project supervision.
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Animal and Human Rights Statement
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
The original online version of this article was revised: In the original version of Fig. 6, the names of image panels (row 2 to row 5) were mislabeled during figure layout.
Supplementary Information
Rights and permissions
About this article
Cite this article
Dan, J., Nie, L., Jia, X. et al. Visualization of the Oncolytic Alphavirus M1 Life Cycle in Cancer Cells. Virol. Sin. 36, 655–666 (2021). https://doi.org/10.1007/s12250-020-00339-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12250-020-00339-7